Publication | Open Access

Phase III randomized study of second line ADI-PEG 20 plus best supportive care versus placebo plus best supportive care in patients with advanced hepatocellular carcinoma

OncologyHepatologyCancer ManagementPhase IiiSurgeryLiver CancerLiver TransplantationMedicineRadiation OncologyHepatocellular CarcinomaAdvanced Hepatocellular Carcinoma